CVS Health Corporation (NYSE:CVS – Get Free Report) announced a quarterly dividend on Friday, July 10th. Stockholders of record on Thursday, July 23rd will be paid a dividend of 0.665 per share by the pharmacy operator on Monday, August 3rd. This represents a c) annualized dividend and a dividend yield of 2.6%. The ex-dividend date is Thursday, July 23rd.
CVS Health has increased its dividend payment by an average of 0.1%per year over the last three years and has raised its dividend every year for the last 4 years. CVS Health has a dividend payout ratio of 37.7% meaning its dividend is sufficiently covered by earnings. Equities analysts expect CVS Health to earn $8.37 per share next year, which means the company should continue to be able to cover its $2.66 annual dividend with an expected future payout ratio of 31.8%.
CVS Health Stock Up 1.3%
Shares of CVS stock traded up $1.34 on Friday, reaching $104.15. 9,149,508 shares of the company’s stock traded hands, compared to its average volume of 8,480,558. The company has a market capitalization of $132.88 billion, a P/E ratio of 45.88, a price-to-earnings-growth ratio of 1.02 and a beta of 0.61. CVS Health has a 12-month low of $58.50 and a 12-month high of $106.15. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.66 and a current ratio of 0.87. The business’s 50 day moving average price is $96.50 and its two-hundred day moving average price is $84.03.
CVS Health News Roundup
Here are the key news stories impacting CVS Health this week:
- Positive Sentiment: CVS Health declared a quarterly dividend of $0.665 per share, reinforcing its shareholder-return policy and signaling management confidence in cash generation. CVS Health declares quarterly dividend
- Positive Sentiment: Coverage around CVS highlighted the company as a likely beneficiary of managed-care consolidation, with commentary that Aetna is handling medical costs and that CVS is well positioned as Walgreens weakens. Cramer’s Stop Trading: CVS Health
- Neutral Sentiment: A CVS executive, Ali Keshavarz, was appointed to the board of Choice Hotels; this is notable for the executive’s profile but does not appear to have a direct operational impact on CVS. Choice Hotels (CHH) Appoints CVS Data Chief To Board As Index Changes Hit
- Negative Sentiment: CVS and Omnicare agreed to a $440 million settlement with the U.S. Department of Justice to resolve improper billing allegations, which creates a large one-time legal cost and keeps regulatory pressure on the company. CVS, Omnicare ink $440M deal with DoJ to resolve improper billing case
- Negative Sentiment: CVS also settled a separate $36.5 million case tied to false Medicaid insulin claims, adding to the legal overhang and reinforcing concerns about compliance risks. CVS settles for $36.5M over false Medicaid insulin claims, Minnesota recovers $400K
CVS Health Company Profile
CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.
Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.
Further Reading
- Five stocks we like better than CVS Health
- AeroVironment Flies Under Wall Street’s Radar Toward a $4 Billion Target
- Micron’s $250 Billion Bet Could Reshape the AI Memory Race
- Rocket Lab’s Stock Drop Comes With a Bullish Twist
- Amazon’s New Debt Deal Puts Its AI Spending Story on Trial
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.
